iRhythm Holdings (IRTC) Capital Expenditures (2015 - 2026)
iRhythm Holdings' (IRTC) quarterly Capital Expenditures came in at $2.0 million in Q1 2026, up 371.74% year-on-year from $419932.8 in Q1 2025, and up 473.07% on a QoQ basis from -$531000.0 in Q4 2025.
iRhythm Holdings (IRTC) Capital Expenditures (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has 12 years of Capital Expenditures data on file, last reported at $2.0 million in Q1 2026.
- On a quarterly basis, Capital Expenditures rose 371.74% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $5.6 million, a 140.83% increase from a year earlier, with the FY2025 full-year figure at $2.9 million, up 189.85% from the prior year.
- Capital Expenditures for Q1 2026 stood at $2.0 million, up from -$531000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for IRTC reached as high as $22.7 million in Q4 2023 and fell as low as -$22.6 million in Q4 2022.
- Historically, Capital Expenditures has averaged $1.4 million across 5 years, with a median of -$531000.0 in 2025.
- Across the five-year window, Capital Expenditures jumped 618.97% in 2022 and plunged 272.56% in 2025, its largest moves.
- Year by year, Capital Expenditures stood at -$22.6 million in 2022, then surged by 200.54% to $22.7 million in 2023, then slumped by 116.9% to -$3.8 million in 2024, then surged by 86.15% to -$531000.0 in 2025, then soared by 473.07% to $2.0 million in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $2.0 million in Q1 2026, -$531000.0 in Q4 2025, and -$16.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 76.60 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 178.00 Mn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | -85.46 Mn |
| 10 | iRhythm Holdings | 3.62 Bn | 3.07 Bn | 141.35 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.98 Mn |
| Mar 31, 2026 | 1.98 Mn |
| Dec 31, 2025 | -531,000.00 |
| Dec 31, 2025 | -531,000.00 |
| Sep 30, 2025 | -16.36 Mn |
| Sep 30, 2025 | -16.36 Mn |
| Jun 30, 2025 | 20.52 Mn |
| Jun 30, 2025 | 20.52 Mn |
| Mar 31, 2025 | -729,000.00 |
| Mar 31, 2025 | -729,000.00 |
| Dec 31, 2024 | -3.84 Mn |
| Dec 31, 2024 | -3.84 Mn |
| Sep 30, 2024 | -4.39 Mn |
| Sep 30, 2024 | -4.39 Mn |
| Jun 30, 2024 | -4.77 Mn |
| Jun 30, 2024 | -4.77 Mn |
| Mar 31, 2024 | 9.78 Mn |
| Mar 31, 2024 | 9.78 Mn |
| Dec 31, 2023 | 22.70 Mn |
| Dec 31, 2023 | 22.70 Mn |